AAM
BNTX icon

Abeille Asset Management’s BioNTech BNTX Stock Holding History

Abeille Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$46M Buy
+4,726
New +$727K 1.63% 16

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Abeille Asset Management's BNTX Position: Q4 2022 in Review

Abeille Asset Management opened a new position in BioNTech (BNTX) in Q4 2022: 4,726 shares worth $46M. The stake represents 1.63% of the portfolio and ranks #16 among its holdings.

320 funds tracked by Wall St. Rank hold BNTX as of Q4 2022.

  • Abeille Asset Management held 4,726 shares of BioNTech worth $46M as of Q4 2022.
  • BioNTech was a new Abeille Asset Management position in Q4 2022.
  • BioNTech made up 1.63% of Abeille Asset Management's portfolio in Q4 2022, its #16 holding.
  • 320 funds tracked by Wall St. Rank held BioNTech as of Q4 2022.

Based on Abeille Asset Management's 13F filing for Q4 2022, filed 20 Jan 2023.